Steve Andrew - Seeking Alpha 'Steve Andrew' Tag RSS Syndication from SeekingAlpha.com SeekingAlpha.com http://seekingalpha.com/author/steve-andrew CCUR: Unknown Stock, Huge Opportunity http://seekingalpha.com/article/140382-ccur-unknown-stock-huge-opportunity?source=feed 140382 Concurrent Computer Corp. (CCUR) supplies global cable operators such as Comcast (CMCSA) and Cox with vital software that makes video on demand possible. CCUR’s technology creates and supports the operation of everything that happens after a cable customer hits the VOD button on his or her remote. This includes the menu and its operation, playing of the selected video feed (movie, TV show, etc.), in video commands (pause, fast forward, etc.), and the process of billing the customer for the VOD purchase. This technology is vital to the operation of the cable companies’ extremely lucrative VOD market. The company also utilizes data gathered during the customer’s VOD sessions to tailor advertising content to specific customers. This technology will continue to accelerate growth as VOD accelerates growth on PCs - think Hulu and YouTube - and mobile devices, such as iPhones.

Currently the VOD business is growing at around 16% YoY for the trailing 9 months but an investor can assume that 20%+ percent growth is achievable in better economic conditions. This business makes up roughly 66% of last quarter’s revenue with the remaining made up by a different video technology utilized in military and industrial applications. During the last quarter the company took a large, non-cash write off of goodwill ($17.1 million), primarily stemming from a 1999 acquisition. Excluding this impairment charge and the related tax benefits, the company earned $1.3 million or $0.16 a share. Future earnings for the company look even stronger as the company’s lone analyst has a $0.70 EPS number for FY2010.

]]> Sat, 30 May 2009 15:46:14 -0400 Steve Andrew Concurrent Computer Corp. (CCUR) supplies global cable operators such as Comcast (CMCSA) and Cox with vital software that makes video on demand possible. CCUR’s technology creates and supports the operation of everything that happens after a cable customer hits the VOD button on his or her remote. This includes the menu and its operation, playing of the selected video feed (movie, TV show, etc.), in video commands (pause, fast forward, etc.), and the process of billing the customer for the VOD purchase. This technology is vital to the operation of the cable companies’ extremely lucrative VOD market. The company also utilizes data gathered during the customer’s VOD sessions to tailor advertising content to specific customers. This technology will continue to accelerate growth as VOD accelerates growth on PCs - think Hulu and YouTube - and mobile devices, such as iPhones.

Currently the VOD business is growing at around 16% YoY for the trailing 9 months but an investor can assume that 20%+ percent growth is achievable in better economic conditions. This business makes up roughly 66% of last quarter’s revenue with the remaining made up by a different video technology utilized in military and industrial applications. During the last quarter the company took a large, non-cash write off of goodwill ($17.1 million), primarily stemming from a 1999 acquisition. Excluding this impairment charge and the related tax benefits, the company earned $1.3 million or $0.16 a share. Future earnings for the company look even stronger as the company’s lone analyst has a $0.70 EPS number for FY2010.


Complete Story »]]> CCUR CMCSA Steve Andrew ClickSoft: Underloved and Undervalued http://seekingalpha.com/article/118694-clicksoft-underloved-and-undervalued?source=feed 118694 ClickSoftware (CKSW), maker of workforce optimization software, reported full year 2008 results yesterday. The results came in above analyst estimates of $52.5 million and $0.17, with the company booking $52.3 million in revenue to go along with net income of $8.1 million or $0.28. According to the conference call, revenue for the year was negatively impacted by about $1.5 million due to foreign currency exchange. The company also reported that total cash had risen to $32 million dollars. In any economic environment, this was a stellar quarter.

ClickSoft is a leader in the industry of making business more efficient. During this recession, every company in the world is trying to find ways to do more with less. Enter Clicksoft. The company’s software suite can do anything from quickly dispatch a gas utility’s closest technician to a service call to schedule the most efficient worker schedule for a big box retailer. ClickSoft sells its product through multiple internal and external channels, most recently announcing a global reselling agreement with [[SAP]]. The company also touts [[IBM]], Accenture (ACN), and Microsoft (MSFT) as global partners. The question remains, with such great results, in not so great economic times, why hasn’t the market taken notice?

]]> Thu, 05 Feb 2009 06:42:22 -0500 Steve Andrew ClickSoftware (CKSW), maker of workforce optimization software, reported full year 2008 results yesterday. The results came in above analyst estimates of $52.5 million and $0.17, with the company booking $52.3 million in revenue to go along with net income of $8.1 million or $0.28. According to the conference call, revenue for the year was negatively impacted by about $1.5 million due to foreign currency exchange. The company also reported that total cash had risen to $32 million dollars. In any economic environment, this was a stellar quarter.

ClickSoft is a leader in the industry of making business more efficient. During this recession, every company in the world is trying to find ways to do more with less. Enter Clicksoft. The company’s software suite can do anything from quickly dispatch a gas utility’s closest technician to a service call to schedule the most efficient worker schedule for a big box retailer. ClickSoft sells its product through multiple internal and external channels, most recently announcing a global reselling agreement with [[SAP]]. The company also touts [[IBM]], Accenture (ACN), and Microsoft (MSFT) as global partners. The question remains, with such great results, in not so great economic times, why hasn’t the market taken notice?


Complete Story »]]> CKSW Steve Andrew Sequenom's Price Not Reflective of Its True Potential http://seekingalpha.com/article/44321-sequenom-s-price-not-reflective-of-its-true-potential?source=feed 44321 At first glance SQNM may look expensive. They have the best in breed gene sequencing system called MassArray that is growing 30% or so a year.

Recurring revenue (total 07 REV is about 42mil) comes from the service of these systems and disposable units used in the gene work. The Market Cap of the company is about 200 mil, so the question was why are the execs buying so much stock? SQNM is developing a series of non-invasive prenatal diagnostics for various birth defects. These tests are currently administered in the 3rd trimester through a fluid draw with an amnio needle. The SQNM test uses nucleic acid in fetal DNA found in maternal blood from a blood draw instead of the amnio fluid. What makes this significant is the amnio test has a 1% to 2% accidental abortion rate, is performed in the 3rd trimester, and has not proved to be 100% accurate.

The SQNM test in trials has proved to be 100% accurate in the 2nd trimester for detecting Down Syndrome and RhD (a condition where the mothers blood and the fetal blood do not match up) and has no risk of an accidental abortion. SQNM’s test is more accurate, earlier, and has no risk of accidental abortion. The RhD test should be ready for approval in the next few weeks and the Downs test by the back half of 08. During the last conference call the time line for the test was moved up significantly.

]]> Mon, 13 Aug 2007 10:12:01 -0400 Steve Andrew At first glance SQNM may look expensive. They have the best in breed gene sequencing system called MassArray that is growing 30% or so a year.

Recurring revenue (total 07 REV is about 42mil) comes from the service of these systems and disposable units used in the gene work. The Market Cap of the company is about 200 mil, so the question was why are the execs buying so much stock? SQNM is developing a series of non-invasive prenatal diagnostics for various birth defects. These tests are currently administered in the 3rd trimester through a fluid draw with an amnio needle. The SQNM test uses nucleic acid in fetal DNA found in maternal blood from a blood draw instead of the amnio fluid. What makes this significant is the amnio test has a 1% to 2% accidental abortion rate, is performed in the 3rd trimester, and has not proved to be 100% accurate.

The SQNM test in trials has proved to be 100% accurate in the 2nd trimester for detecting Down Syndrome and RhD (a condition where the mothers blood and the fetal blood do not match up) and has no risk of an accidental abortion. SQNM’s test is more accurate, earlier, and has no risk of accidental abortion. The RhD test should be ready for approval in the next few weeks and the Downs test by the back half of 08. During the last conference call the time line for the test was moved up significantly.


Complete Story »]]> SQNM Steve Andrew